Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

US Patent 11944612 · Granted Apr 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)me2021
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)me2021
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)me2021
Unit dose formulation of antidotes for factor Xa inhibitors and methods of using2020
Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)met2019
Modified release formulations for oprozomib2016
Unit dose formulation of antidotes for factor Xa inhibitors and methods of using2015